Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för LaBarre Michael J.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att LaBarre Michael J. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:HALO / Halozyme Therapeutics, Inc. | SVP, CHIEF TECHNICAL OFFICER | 173 756 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av LaBarre Michael J.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp HALO / Halozyme Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i HALO / Halozyme Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i HALO / Halozyme Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-16 | HALO | LaBarre Michael J. | 2 878 | 49,2600 | 2 878 | 49,2600 | 141 770 | 81 | 30.2800 | −54 624 | −38,53 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av LaBarre Michael J. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 173 756 | −0,06 | 58,74 | −5 874 | 10 206 427 |
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 597 | 173 856 | −0,91 | 58,25 | −93 028 | 10 127 460 |
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 | 175 453 | −0,34 | 58,65 | −35 189 | 10 289 968 |
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 400 | 176 053 | −5,07 | 58,09 | −546 055 | 10 227 095 |
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −700 | 185 453 | −0,38 | 58,67 | −41 069 | 10 880 528 |
2025-02-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 300 | 186 153 | −4,76 | 58,01 | −539 465 | 10 798 177 |
2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 410 | 195 453 | −1,22 | 57,75 | −139 178 | 11 287 411 | |
2025-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 4 747 | 197 863 | 2,46 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 164 | 193 116 | −1,11 | 58,29 | −126 140 | 11 256 732 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 4 263 | 195 280 | 2,23 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −3 103 | 191 017 | −1,60 | 58,29 | −180 874 | 11 134 381 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 6 112 | 194 120 | 3,25 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −8 721 | 188 008 | −4,43 | 58,29 | −508 347 | 10 958 986 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 20 891 | 196 729 | 11,88 | ||||
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 304 | 175 838 | −0,74 | 58,29 | −76 010 | 10 249 597 | |
2025-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 386 | 177 142 | 1,95 | ||||
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 173 756 | −5,44 | 53,26 | −532 590 | 9 254 071 |
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 183 756 | 5,76 | 19,98 | 199 800 | 3 671 445 |
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −77 | 173 756 | −0,04 | 54,24 | −4 177 | 9 425 394 |
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 923 | 173 833 | −5,40 | 53,74 | −533 292 | 9 342 307 |
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 4 491 | 183 756 | 2,51 | 19,98 | 89 730 | 3 671 445 |
2024-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 5 509 | 179 265 | 3,17 | 16,65 | 91 725 | 2 984 762 |
2024-09-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 037 | 173 756 | −1,16 | 62,58 | −127 477 | 10 873 824 |
2024-09-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 963 | 175 793 | −4,33 | 61,89 | −492 838 | 10 880 005 |
2024-09-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 183 756 | 5,76 | 16,65 | 166 500 | 3 059 537 |
2024-09-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 173 756 | −5,44 | 62,88 | −628 780 | 10 925 430 |
2024-09-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 183 756 | 5,76 | 16,65 | 166 500 | 3 059 537 |
2024-08-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 580 | 173 756 | 3,32 | 18,41 | 102 728 | 3 198 848 | |
2024-08-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 168 176 | −0,06 | 62,34 | −6 234 | 10 484 092 |
2024-08-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 900 | 168 276 | −5,56 | 61,74 | −611 236 | 10 389 529 |
2024-08-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 16,65 | 166 500 | 2 966 630 |
2024-08-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 61,06 | −610 550 | 10 267 986 |
2024-08-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 16,65 | 166 500 | 2 966 630 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 55,12 | −551 150 | 9 269 020 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 285 | 178 176 | 4,88 | 16,65 | 137 945 | 2 966 630 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 715 | 169 891 | 1,02 | 8,11 | 13 909 | 1 377 816 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 291 | 168 176 | −3,05 | 55,26 | −292 407 | 9 294 247 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 709 | 173 467 | −2,64 | 54,46 | −256 466 | 9 447 533 |
2024-07-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-06-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 49,43 | −494 260 | 8 312 267 |
2024-06-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 45,38 | −453 840 | 7 632 500 |
2024-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 45,16 | −451 640 | 7 595 501 |
2024-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-04-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 38,49 | −384 890 | 6 472 926 |
2024-04-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-04-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 168 176 | −5,61 | 38,35 | −383 500 | 6 449 550 |
2024-04-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 178 176 | 5,95 | 8,11 | 81 100 | 1 445 007 |
2024-03-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 890 | 168 176 | 1,75 | 8,11 | 23 438 | 1 363 907 | |
2024-03-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 292 | 165 286 | 0,18 | 16,78 | 4 900 | 2 773 499 | |
2024-03-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 436 | 164 994 | 5,39 | 12,07 | 101 823 | 1 991 478 | |
2024-03-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 156 558 | −6,00 | 42,27 | −422 730 | 6 618 176 |
2024-03-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 551 | 166 558 | 2,18 | 8,11 | 28 799 | 1 350 785 |
2024-03-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 6 449 | 163 007 | 4,12 | 12,07 | 77 839 | 1 967 494 |
2024-03-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 156 558 | −6,00 | 41,64 | −416 370 | 6 518 605 |
2024-03-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 166 558 | 6,39 | 12,07 | 120 700 | 2 010 355 |
2024-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 471 | 156 558 | −4,55 | 39,54 | −295 418 | 6 190 616 |
2024-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 471 | 164 029 | 4,77 | 8,11 | 60 590 | 1 330 275 |
2024-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 529 | 156 558 | −1,59 | 39,56 | −100 045 | 6 193 278 |
2024-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 159 087 | −5,91 | 39,95 | −399 460 | 6 354 889 |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 160 | 169 087 | −1,26 | 36,10 | −77 976 | 6 104 041 | |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 4 264 | 171 247 | 2,55 | ||||
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −3 097 | 166 983 | −1,82 | 36,10 | −111 802 | 6 028 086 | |
2024-02-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 6 112 | 170 080 | 3,73 | ||||
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −3 832 | 163 968 | −2,28 | 35,91 | −137 607 | 5 888 091 | |
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
A - Award | 8 479 | 167 800 | 5,32 | ||||
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 208 | 159 321 | −0,75 | 35,91 | −43 379 | 5 721 217 | |
2024-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 386 | 160 529 | 2,15 | ||||
2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 901 | 157 143 | −1,81 | 35,49 | −102 956 | 5 577 005 | |
2024-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 133 | 160 044 | 5,35 | ||||
2024-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 36,00 | −360 000 | 5 468 796 |
2024-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 12,07 | 120 700 | 1 954 266 |
2024-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 36,00 | −360 000 | 5 468 796 |
2024-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 12,07 | 120 700 | 1 954 266 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 40,39 | −403 940 | 6 136 293 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 12,07 | 120 700 | 1 954 266 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −643 | 151 911 | −0,42 | 40,46 | −26 019 | 6 147 079 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 357 | 152 554 | −5,78 | 39,58 | −370 303 | 6 037 325 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 467 | 161 911 | 0,91 | 12,07 | 17 707 | 1 954 266 |
2023-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 533 | 160 444 | 5,62 | 13,81 | 117 841 | 2 215 732 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 39,79 | −397 880 | 6 044 235 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 13,81 | 138 100 | 2 235 991 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 708 | 151 911 | −1,11 | 39,08 | −66 747 | 5 936 530 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 708 | 153 619 | 1,12 | 16,78 | 28 660 | 2 577 727 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 292 | 151 911 | −5,18 | 39,08 | −324 043 | 5 936 530 |
2023-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 292 | 160 203 | 5,46 | 13,81 | 114 513 | 2 212 403 |
2023-10-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 36,52 | −365 200 | 5 547 790 |
2023-10-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 19,98 | 199 800 | 3 234 982 |
2023-09-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 151 911 | −6,18 | 39,10 | −390 980 | 5 939 416 |
2023-09-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 161 911 | 6,58 | 19,98 | 199 800 | 3 234 982 |
2023-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 075 | 151 911 | −5,05 | 42,41 | −342 437 | 6 442 090 |
2023-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 075 | 159 986 | 5,32 | 19,98 | 161 338 | 3 196 520 |
2023-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 925 | 151 911 | −1,25 | 42,41 | −81 633 | 6 442 090 |
2023-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 925 | 153 836 | 1,27 | 18,41 | 35 439 | 2 832 121 |
2023-07-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 825 | 151 911 | 1,89 | 8,11 | 22 911 | 1 231 998 | |
2023-07-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 175 | 149 086 | 5,06 | 13,81 | 99 087 | 2 058 878 | |
2023-07-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 141 911 | −6,58 | 40,43 | −404 300 | 5 737 462 |
2023-07-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 151 911 | 7,05 | 18,41 | 184 100 | 2 796 682 |
2023-06-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 141 911 | −6,58 | 36,00 | −360 000 | 5 108 796 |
2023-06-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 151 911 | 7,05 | 18,41 | 184 100 | 2 796 682 |
2023-04-19 |
|
4/A | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 984 | 141 911 | −2,06 | 49,55 | −147 854 | 7 031 548 |
2023-04-19 |
|
4/A | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 984 | 144 895 | 2,10 | 18,41 | 54 935 | 2 667 517 |
2023-04-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 141 911 | −6,58 | 36,00 | −360 000 | 5 108 796 |
2023-04-19 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 10 000 | 151 911 | 7,05 | 18,41 | 184 100 | 2 796 682 |
2023-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 984 | 138 927 | −2,10 | 49,55 | −147 854 | 6 883 694 |
2023-02-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 016 | 141 911 | −4,71 | 49,55 | −347 629 | 7 031 406 |
2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | −2 878 | 148 927 | −1,90 | 49,26 | −141 770 | 7 336 144 | |
2023-02-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 6 112 | 151 805 | 4,20 | ||||
2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 170 | 145 693 | −0,80 | 49,20 | −57 564 | 7 168 096 | |
2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 386 | 146 863 | 2,36 | ||||
2023-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 143 477 | −6,52 | 48,39 | −483 940 | 6 943 426 |
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 725 | 153 477 | −1,74 | 48,92 | −133 307 | 7 508 095 | |
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 883 | 156 202 | 5,31 | ||||
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 951 | 148 319 | −1,95 | 48,92 | −144 363 | 7 255 765 | |
2023-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 133 | 151 270 | 5,68 | ||||
2023-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 122 | 143 137 | −0,78 | 50,93 | −57 139 | 7 289 395 |
2023-01-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 878 | 144 259 | −5,80 | 50,40 | −447 451 | 7 270 654 |
2022-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 065 | 153 137 | −3,20 | 58,66 | −297 133 | 8 983 629 |
2022-12-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 935 | 158 202 | −3,03 | 58,67 | −289 541 | 9 281 870 |
2022-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 115 | 163 137 | −1,87 | 54,14 | −168 643 | 8 832 074 |
2022-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 | 166 252 | 0,00 | 54,61 | −437 | 9 079 022 |
2022-11-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 877 | 166 260 | −3,97 | 54,12 | −372 183 | 8 997 991 |
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 24 448 | 24 448 | |||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 74 777 | 74 777 | |||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −3 386 | 10 158 | −25,00 | ||||
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 170 | 173 137 | −0,67 | 34,43 | −40 283 | 5 961 107 | |
2022-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 386 | 174 307 | 1,98 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −5 771 | 0 | −100,00 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 995 | 170 921 | −1,15 | 33,64 | −67 112 | 5 749 782 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 771 | 172 916 | 3,45 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −7 883 | 7 883 | −50,00 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 725 | 167 145 | −1,60 | 34,20 | −93 195 | 5 716 359 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 883 | 169 870 | 4,87 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −8 133 | 16 266 | −33,33 | ||||
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 992 | 161 987 | −1,81 | 34,94 | −104 540 | 5 659 826 | |
2022-02-14 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 133 | 164 979 | 5,19 | ||||
2021-10-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −8 050 | 0 | −100,00 | ||||
2021-10-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 050 | 156 846 | 5,41 | 13,10 | 105 455 | 2 054 683 | |
2021-10-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −29 450 | 8 050 | −78,53 | ||||
2021-10-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −29 450 | 148 796 | −16,52 | 39,93 | −1 175 968 | 5 941 573 |
2021-10-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 29 450 | 178 246 | 19,79 | 13,10 | 385 795 | 2 335 023 |
2021-07-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −14 685 | 0 | −100,00 | ||||
2021-07-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 14 685 | 148 796 | 10,95 | 6,55 | 96 187 | 974 614 | |
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −40 315 | 14 685 | −73,30 | ||||
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −40 315 | 134 111 | −23,11 | 45,70 | −1 842 315 | 6 128 604 |
2021-07-06 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 40 315 | 174 426 | 30,06 | 6,55 | 264 063 | 1 142 490 | |
2021-05-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −11 311 | 0 | −100,00 | ||||
2021-05-03 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 311 | 134 111 | 9,21 | 11,29 | 127 701 | 1 514 113 | |
2021-04-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −28 689 | 11 311 | −71,72 | ||||
2021-04-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 994 | 122 800 | −13,40 | 42,79 | −812 829 | 5 255 103 |
2021-04-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 695 | 141 794 | −6,40 | 42,10 | −408 208 | 5 970 236 |
2021-04-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 28 689 | 151 489 | 23,36 | 11,29 | 323 899 | 1 710 311 | |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 530 | 122 800 | −5,05 | 46,26 | −302 061 | 5 680 409 |
2021-03-01 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 794 | 129 330 | −8,36 | 45,56 | −537 303 | 5 891 926 |
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −8 803 | 0 | −100,00 | ||||
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −4 364 | 141 124 | −3,00 | 48,69 | −212 483 | 6 871 328 | |
2021-02-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 803 | 145 488 | 6,44 | ||||
2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 13 544 | 13 544 | |||||
2021-02-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 23 311 | 23 311 | |||||
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −5 771 | 5 771 | −50,00 | ||||
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 272 | 136 685 | −1,64 | 49,84 | −113 236 | 6 812 380 | |
2021-02-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 771 | 138 957 | 4,33 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −7 883 | 15 766 | −33,33 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 725 | 133 186 | −2,00 | 49,84 | −135 814 | 6 637 990 | |
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 883 | 135 911 | 6,16 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −8 134 | 24 399 | −25,00 | ||||
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 906 | 128 028 | −2,22 | 50,60 | −147 044 | 6 478 217 | |
2021-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 134 | 130 934 | 6,62 | ||||
2020-12-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 | 122 800 | −0,49 | 43,25 | −25 951 | 5 311 346 |
2020-12-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 400 | 123 400 | −8,46 | 42,54 | −484 967 | 5 249 559 |
2020-11-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 889 | 134 800 | −5,53 | 39,04 | −307 955 | 5 262 053 |
2020-11-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 111 | 142 689 | −2,80 | 38,24 | −157 221 | 5 456 998 |
2020-10-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 000 | 146 800 | −7,56 | 30,43 | −365 148 | 4 466 977 |
2020-09-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 000 | 158 800 | −7,03 | 26,91 | −322 884 | 4 272 832 |
2020-08-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 000 | 170 800 | −6,56 | 28,30 | −339 564 | 4 833 128 |
2020-07-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 000 | 182 800 | −6,16 | 29,01 | −348 072 | 5 302 297 |
2020-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −18 613 | 0 | −100,00 | ||||
2020-05-22 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 18 613 | 194 800 | 10,56 | 7,14 | 132 897 | 1 390 872 | |
2020-05-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
M - Exercise | −21 387 | 18 613 | −53,47 | ||||
2020-05-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −21 387 | 176 187 | −10,82 | 23,80 | −509 075 | 4 193 779 |
2020-05-21 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 387 | 197 574 | 12,14 | 7,14 | 152 703 | 1 410 678 | |
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −8 803 | 8 803 | −50,00 | ||||
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −3 044 | 176 187 | −1,70 | 21,83 | −66 451 | 3 846 162 | |
2020-02-24 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 803 | 179 231 | 5,17 | ||||
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −5 772 | 11 542 | −33,34 | ||||
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −1 995 | 170 428 | −1,16 | 21,10 | −42 094 | 3 596 031 | |
2020-02-18 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 772 | 172 423 | 3,46 | ||||
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
M - Exercise | −7 883 | 23 649 | −25,00 | ||||
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −2 725 | 166 651 | −1,61 | 20,00 | −54 500 | 3 333 020 | |
2020-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 883 | 169 376 | 4,88 | ||||
2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Restricted Stock Units |
A - Award | 32 533 | 32 533 | |||||
2020-02-12 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock |
A - Award | 69 174 | 69 174 | |||||
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 559 | 0 | −100,00 | ||||
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
F - Taxes | −4 289 | 161 493 | −2,59 | 19,21 | −82 392 | 3 102 281 | |
2020-02-04 |
|
4 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 559 | 165 782 | 7,49 | ||||
2020-01-06 | 3 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
308 446 | ||||||||
2020-01-06 | 3 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
308 446 | ||||||||
2020-01-06 | 3 | HALO |
HALOZYME THERAPEUTICS, INC.
Common Stock |
308 446 |